Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Australian Veterinary Journal|May 14, 1998
Mitotane (o,p'-DDD) resistance in a dog with pituitary-dependent hyperadrenocorticism and phaeochromocytomaP F Bennett, E J NormanAustralian Veterinary Journal|April 2, 2009
Metastatic mast cell tumour in a dog presenting with spinal painM A Cooper, P F Bennett, P H LavertyAustralian Veterinary Journal|March 23, 2011
CCNU (lomustine) toxicity in dogs: a retrospective study (2002-07)K L Heading, L K Brockley, P F BennettNew Zealand Veterinary Journal|August 24, 2012
Malignant melanoma in 63 dogs (2001-2011): the effect of carboplatin chemotherapy on survivalL K Brockley, M A Cooper, P F BennettAustralian Veterinary Journal|January 30, 2019
Lymphoma in Australian Border Collies: survey results and pedigree analysesK Y Cheng, Pxy Soh, P F Bennett, et al.Journal of the American Animal Hospital Association|September 21, 2001
Ultrasonographic and cytopathological diagnosis of exocrine pancreatic carcinoma in the dog and catP F Bennett, K A Hahn, R L Toal, et al.Australian Veterinary Journal|December 24, 1997
Idiopathic eosinophilic meningoencephalitis in rottweiler dogs: three cases (1992-1997)P F Bennett, F J Allan, W G Guilford, et al.Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 25, 2005
Pretreatment tumor prostaglandin E2 concentration and cyclooxygenase-2 expression are not associated with the response of canine naturally occurring invasive urinary bladder cancer to cyclooxygenase inhibitor therapyA J Mutsaers, S I Mohammed, D B DeNicola, et al.Pageof 1